Addresses 1 Isala Klinieken, Background In patients with ST-segment elevation acute myocardial infarction (STEMI), elevated cardiac troponin T (cTnT) on admission is associated with poorer outcomes despite early reperfusion. Presentation delay is thought to be the most important factor for the elevation of cTnT on admission. We evaluated presentation delay and other potential predictors of elevated cTnT on admission in patients treated with primary percutaneous coronary interventions (PCI) for STEMI.
Introduction
Several studies have demonstrated that an elevated cardiac troponin T (cTnT) on admission in patients with ST-segment elevation myocardial infarction (STEMI) predicts short-and long-term mortality and failure of thrombolytic therapy or primary percutaneous coronary interventions (PCI). 1--5 Giannitsis et al. 6 found that elevated cTnT on admission in STEMI predicts lower rates of post procedural thrombolysis in myocardial infarction (TIMI) grade 3 £ow, more severely compromised myocardial perfusion despite normal epicardial £ow and higher rates of all-cause and cardiac mortality. They also concluded that cTnT-positive patients might require more aggressive adjunctive therapy when treated with primary PCI. Although cTnT may be elevated within 2 h after symptom onset, 3, 6 it is generally believed that cTnT elevations are mostly seen at a minimum of 3--4 h after the onset of chest pain. 7 Previous reports were hampered by relatively small sample sizes, and predictors of elevated cTnT on admission are not yet clear. The present study was designed to identify the independent predictors of elevated cTnT on admission in a large population of STEMI patients treated with primary PCI and to study the mechanism of cTnT elevation early after symptom onset.
Patients and methods
From June 2001to November 2002,507 consecutive patients were enrolled in the On-TIME trial. Patients with STEMI who were transferred to a PCI centre were randomized to early (pre-hospital) or late (catheterization laboratory) initiation of Tiro¢ban. Inclusion and exclusion criteria have been described previously. 8 In brief, patients with chest pain of 430 min duration and electrocardiogram (ECG) changes with ST-segment elevation 42 mm in the precordial leads and 41mm in the limb leads in at least two contiguous leads were included in the study. The ability to perform PCI within 6 h after symptom onset was also an enrolment criterion. The exclusion criteria were age more than 80 years, age less than 50 years in women, treatment with thrombolytic therapy in the previous 24 h, warfarin or acenocoumarol therapy within the last seven days and contraindication to glycoprotein 2b/3a blockade. Patients with severe heart failure or cardiogenic shock (Killip class III or IV) and patients who were on haemodialysis were also excluded.
Each institution's Review Board or Ethical Committee approved this study and all patients gave written informed consent. The study population consisted of 444 patients (88%) in whom cTnT was measured on admission. Patients were strati¢ed into cTnT positive and cTnT negative. Baseline characteristics, angiographic parameters and clinical outcome were compared between the cTnT-positive and cTnT-negative patients.
Presentation delay was de¢ned as the time from symptom onset to infarct diagnosis (¢rst ECG). Ischaemic time was de¢ned as time from symptom onset to ¢rst balloon in£ation.
Serum marker analyses
cTnT concentrations were measured using a pointof-care system (Cardiac Reader [Roche Diagnostics, Almere, The Netherlands]). cTnT 40.05 mg/L was considered to be positive.
Creatine kinase (CK), creatine kinase MB (CK-MB) activity and cumulative lactate dehydrogenase (LDH Q48 ) concentrations were analysed with the Elecsys 2010 system (Roche Diagnostics). Glucose was measured by means of a hexokinase method using a Modular PPE module device (Roche Analytics, Almere, The Netherlands). High-sensitivity C-reactive protein (hsCRP) was measured by immunochemical analyses (Modular [Roche, Almere, The Netherlands]) and the white blood cell count (WBC) was determined on the Sysmex XE 2100 (Go⁄n Meyvis, Etten-Leur, The Netherlands).
To evaluate the relation between symptom onset to admission time and elevated cTnT, we strati¢ed the patients according to presentation delay. This resulted in an early group who presented within 120 min after symptom onset, an intermediate group who presented between 120 and 180 min after symptom onset, and a late group who presented more than 180 min after symptom onset.
Angiographic data analysis
All angiograms were analysed by an independent core lab (Diagram B.V., Zwolle, The Netherlands) who were blinded to all data apart from the coronary angiogram. TIMI £ow grades and myocardial blush grade (MBG) were assessed after the angioplasty procedure, as previously described. 9, 10 Residual stenosis was assessed visually. Procedural success was de¢ned as postprocedural TIMI 3 £ow of the infarct related vessel and residual stenosis less than 50%. Left ventricular ejection fraction (LVEF) was assessed angiographically.
ST-segment resolution
For assessment of ST-segment resolution, serial 12-lead ECG recordings just before PCI and immediately after return to the coronary care unit were analysed by the same core lab blinded to the clinical data. ECGs with bundle-branch block, pacemaker rhythm, or incomplete or poorly interpretable ECG recordings were not included in this analysis. The ST segment in the lead showing maximal deviation was measured 60 ms after the J point. The resolution of the ST segment was calculated in relative reductions from baseline expressed as percentage.
Follow-up
Records of included patients who visited our outpatient clinic were reviewed. For all other patients, information was obtained from the patient's general physician or by direct telephone interview with the patient. For patients who died during follow-up, hospital records and necropsy data were reviewed. Patients were followed up prospectively for one year by use of hospital records, questionnaire and telephone contact.
Statistical analysis
Statistical analysis was performed with the Statistical Package for the Social Sciences version 12.0.1 (SPSS Inc., Chicago, IL, USA). Continuous data were expressed as mean7standard deviation of mean or median and 25th--75th percentiles and categorical data as percentage, unless otherwise denoted. The analysis of variance and the w 2 -test were appropriately used for continuous and categorical variables, respectively. A multivariate logistic regression analysis was performed to identify independent predictors of high troponin concentration at admission. Signi¢cant variables analysed are reported with their respective odd ratios (OR) and 95% con¢dence intervals (CI). For all analyses, statistical signi¢cance was assumed when the two-tailed probability value was o0.05.
Results
Baseline cTnT on admission was measured in 444 patients. The mean age of these patients was 61.7 years and they were admitted at a median of 155 min after symptom onset. Almost 50% of the patients had an elevated cTnT on admission.
Clinical characteristics of the study group strati¢ed by admission cTnT are displayed in Table 1 . Patients with elevated cTnT on admission were signi¢cantly older, more likely to be female, and were more likely to have a heart rate 4100 bpm or an anterior myocardial infarct location. Presentation delay (median 106 versus 80 min) was longer and Killip class 41 was signi¢-cantly more often present in cTnT-positive patients. Admission CK and CK-MB were signi¢cantly higher in cTnT-positive patients. WBC was comparable in both groups but hsCRP was signi¢cantly higher in cTnT-positive patients. Prevalence of elevated admission cTnT was 33% in the early group, 46% in the intermediate group and 62% in the late group (Figure 1) . Prevalence of increased cTnT was 54% in the early Tiro¢ban group compared with 46% in the late Tiro¢ban group (P ¼ 0.06).
Angiographic findings
Multivessel disease and thrombus load were comparable in cTnT-positive and cTnT-negative patients (56 versus 54 and 31 versus 27%, respectively) ( Table 2) . Pre-PCI TIMI 3 and TIMI 2,3 were signi¢cantly higher in cTnT-positive patients (21 versus 13%, P ¼ 0.03 and 45 versus 32%, P ¼ 0.008, respectively). Post-PCI TIMI 3 £ow and MBG 3 were both signi¢cantly lower in cTnT-positive patients (87 versus 93%, P ¼ 0.048 and 42 versus 63%, Po0.001, respectively). LVEF was sig-ni¢cantly lower in cTnT-positive patients.
Infarct size and outcome
LDH Q48 and cumulative ST-segment elevation tended to be higher in the cTnT-positive patients. No signi¢cant di¡erence was found in ST-segment resolution between cTnT-positive and cTnT-negative patients ( Table 1) . At 30 days, cardiac and all-cause mortality tended to be higher in the cTnT-positive patients. At one year, cardiac death (3.4 versus 0.4%, P ¼ 0.03) and all-cause mortality (4.9 versus 1.3% P ¼ 0.03) were signi¢cantly higher in cTnT-positive patients. Rates of combined reinfarction and/or death were not statistically di¡erent in both groups (Figure 2 ).
Multivariate analysis
To assess the independent predictors of an elevated cTnTon admission, we performed a multivariate analysis and included age, gender, infarct location, Killip class, diabetes, previous PCI, heart rate 4100 bpm, hsCRP and presentation delay. Age (years), hsCRP (mg/mL) and presentation delay (minutes) were included as continuous variables. Multivariate analysis revealed that age (OR 1.03; 95% CI 1.01--1.06, P ¼ 0.01), anterior MI (OR 2.98; 95% CI 1.78--4.99, P ¼ o0.001) and presentation per 30 min (OR 1.23; 95% CI 1.10--1.39, Po0.001) were independent predictors of an elevated cTnT on admission (Table 3 ).
Discussion
This study demonstrates that, apart from presentation delay, anterior myocardial infarct location and higher age are also independent predictors of elevated cTnT on admission. In this study, elevated cTnTon admission is also associated with worse angiographic and clinical outcome, despite primary PCI and treatment with Tiro¢ban.
Predictors of admission cTnT
Our data show that in patients with STEMI, cTnT identi¢es a high-risk group characterized by Killip class 41, older age and an anterior myocardial infarct location. A previous study 7 emphasized that cTnT elevations are seen at a minimum 3--4 h after the onset of symptoms. Other studies, however, reported an elevated cTnT on admission within 2 h after symptom onset. 3 Figure 2 Short-and long-term outcomes. At 30 days rates of cardiac death and all causes of mortality were not significantly different between both groups. However, at one year rates of cardiac death and all causes of mortality were significantly higher in the cTnT-positive patients
We consistently found that admission delay was associated with elevated cTnT on admission. 6 Nevertheless, almost 50% of the patients had an elevated cTnT on admission, whereas even patients with short presentation delay (o120 min after symptom onset) had a relatively high prevalence of elevated cTnT (33%). Why patients with short symptom duration would have an elevated cTnT on admission is not yet clear. In these patients, the onset of symptoms may have gone undetected and thus the true onset of the infarction could have begun much earlier. They could have had a previous silent event that caused cTnT release. 3 A previous study reported that acute coronary occlusion in STEMI is often the ¢nal stage in a series of successive events that occurred in the preceding days or weeks. 11 Another possible explanation of elevated cTnT shortly after symptom onset is a large area at risk; cTnT-positive patients had higher concentrations of peak CK-MB and lower LVEF (Tables 1 and 2 ). Furthermore, the absence of collaterals may also explain the elevated troponin on admission. Matetzky et al. 5 found that patients with elevated troponin are less likely to have collateral blood £ow. In addition, in the current study patients with elevated cTnTon admission more often had a Killip class 41, which, as we previously reported, is associated with worse outcome in STEMI patients. 12 
Prognostic value
Previous studies have demonstrated that both thrombolysis and primary PCI therapy are less e¡ective in cTnT-positive patients. 2, 4, 5, 13 Others have found that epicardial £ow (TIMI £ow o3) remained more frequently compromised and myocardial reperfusion (as measured by serum cardiac markers) was more impaired in cTnT-positive than in cTnT-negative patients. 6 Our data con¢rm that elevated cTnT is associated with impaired myocardial perfusion, as measured by MBG, and lower rates of post-PCI epicardial TIMI 3 £ow. Previous studies 14, 15 showed that pre-procedural patency (TIMI 2 or 3) is associated with favourable out-come. In our study, we found that outcome was worse in cTnT-positive patients, although these patients had higher initial patency rate of the infarct-related vessel. This may be caused by early washout of cardiac enzymes in patients who presented with an open infarctrelated vessel ( Table 2 ). In addition, the higher rates of TIMI 3 £ow in cTnT-positive patients could also be explained by the higher rates of anterior myocardial infarct location (Table 1) , since it has been found that patients with such a location more often have a patent infarct-related vessel than patients with a non-anterior infarct location. 16 In addition, our study con¢rms the results of a previous study 17 that found an inverse relation between LVEF and cTnT. Our results are also consistent with those of Kurowski et al., 18 who found a poorer outcome in patients with elevated troponin compared with patients with normal troponin values on admission.
Implication for treatment
Because patients with elevated cTnTon admission have a worse prognosis, e¡orts should be made to improve their treatment. Although glycoprotein 2b/3a inhibitors have limited value in a general population with STEMI treated with primary PCI and coronary stenting, 19 in patients with elevated cTnTon admission there may be more clear e¡ects.
Limitations
This study is a post hoc, observational analysis and the results were obtained in patients who underwent primary PCI and may not relate to patients treated with thrombolytic therapy. Second, cTnT was measured using a point-of-care reader that only identi¢ed patients with troponin concentrations 40.05 mg/L. By de¢nition, however, patients with concentrations 40.03 mg/L are classi¢ed as non-STEMI and increased risk has been reported by the TACTICS TIMI 18 Study Group even at concentrations close to the lower detection limit. 20 Thus, it is likely that the On-TIME substudy has underestimated the true proportion and risk in this subset. Nevertheless, studies using higher cut-o¡ values found similar results. 3, 6 Another limitation is that we measured CK-MB activity and not CK-MB mass, which is more sensitive and more speci¢c.
Conclusion
This study shows a high prevalence of elevated cTnTon admission in patients with STEMI treated with primary PCI, even in patients who presented early after symptom onset. Apart from presentation delay, increasing age and patients with anterior infarct location are also independent predictors of elevated cTnT on admission. 
